Description of apheresis collection procedures
| . | No. . |
|---|---|
| No. procedures | |
| 1 | 18 |
| 2 | 11 |
| 3 | 1 |
| Venous access | |
| Vein/vein | 28 |
| Catheter4-150 | 2 |
| Blood volume processed, L, median (range) | 12 (10.8-20.0) |
| Duration of apheresis procedure, min, median (range) | 152 (121-241) |
| Apheresis complications | |
| Needle infiltration | 2 |
| Citrate reaction | 6 |
| Phlebitis | 1 |
| Hematoma | 1 |
| Report of pain4-151 | |
| Day 1 | 1/27 |
| Day 2 | 11/24 |
| Day 3 | 22/24 |
| Day 4 | 24/25 |
| Day 5 | 23/24 |
| . | No. . |
|---|---|
| No. procedures | |
| 1 | 18 |
| 2 | 11 |
| 3 | 1 |
| Venous access | |
| Vein/vein | 28 |
| Catheter4-150 | 2 |
| Blood volume processed, L, median (range) | 12 (10.8-20.0) |
| Duration of apheresis procedure, min, median (range) | 152 (121-241) |
| Apheresis complications | |
| Needle infiltration | 2 |
| Citrate reaction | 6 |
| Phlebitis | 1 |
| Hematoma | 1 |
| Report of pain4-151 | |
| Day 1 | 1/27 |
| Day 2 | 11/24 |
| Day 3 | 22/24 |
| Day 4 | 24/25 |
| Day 5 | 23/24 |
Data show the number of donors, except for blood volume processed and duration.
The donor treated with a femoral vein catheter underwent processing of 20 L blood in order to reach the target dose of CD34+ cells from one collection procedure.
Data show the number of donors with reports of pain documented by the nursing staff each morning before the administration of filgrastim. Donor complaints were not documented for all visits. The denominator indicates the total number of donors with nursing notes for each day of filgrastim administration. Day 1 is the first day of filgrastim administration; day 5 is the first day of apheresis (day −1).